Pacific Biosciences Of California Return on Investment 2010-2024 | PACB

Current and historical return on investment (ROI) values for Pacific Biosciences Of California (PACB) over the last 10 years.
Pacific Biosciences Of California ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-03-31 $-0.32B $1.54B -27.05%
2023-12-31 $-0.33B $1.59B -41.11%
2023-09-30 $-0.33B $1.66B -42.75%
2023-06-30 $-0.33B -43.71%
2023-03-31 $-0.32B -28.15%
2022-12-31 $-0.31B $1.46B -19.90%
2022-09-30 $-0.29B $1.52B -17.82%
2022-06-30 $-0.29B $1.58B -17.19%
2022-03-31 $-0.26B $1.63B -16.43%
2021-12-31 $-0.21B $1.69B -14.67%
2021-09-30 $-0.17B $1.74B -16.72%
2021-06-30 $-0.12B $1.15B -20.60%
2021-03-31 $-0.11B $1.18B -36.05%
2020-12-31 $-0.11B inf%
2020-09-30 $-0.10B inf%
2020-06-30 $-0.10B inf%
2020-03-31 $-0.10B inf%
2019-12-31 $-0.10B inf%
2019-09-30 $-0.11B -350.39%
2019-06-30 $-0.11B -160.00%
2019-03-31 $-0.11B -115.20%
2018-12-31 $-0.10B $0.13B -82.93%
2018-09-30 $-0.09B $0.15B -79.48%
2018-06-30 $-0.09B $0.10B -82.98%
2018-03-31 $-0.09B $0.12B -80.00%
2017-12-31 $-0.09B $0.10B -85.71%
2017-09-30 $-0.09B $0.11B -82.66%
2017-06-30 $-0.08B $0.13B -77.54%
2017-03-31 $-0.08B $0.08B -72.21%
2016-12-31 $-0.07B $0.10B -65.01%
2016-09-30 $-0.06B $0.11B -51.16%
2016-06-30 $-0.04B $0.12B -37.63%
2016-03-31 $-0.03B $0.10B -37.84%
2015-12-31 $-0.03B $0.09B -45.34%
2015-09-30 $-0.05B $0.06B -78.95%
2015-06-30 $-0.06B $0.05B -93.72%
2015-03-31 $-0.06B $0.06B -95.45%
2014-12-31 $-0.06B $0.07B -83.22%
2014-09-30 $-0.06B $0.07B -78.21%
2014-06-30 $-0.07B $0.07B -85.38%
2014-03-31 $-0.08B $0.09B -78.53%
2013-12-31 $-0.08B $0.08B -75.18%
2013-09-30 $-0.08B $0.10B -100.00%
2013-06-30 $-0.09B $0.11B -93.99%
2013-03-31 $-0.09B $0.12B -88.12%
2012-12-31 $-0.10B -84.77%
2012-09-30 $-0.10B $0.13B -59.88%
2012-06-30 $-0.10B $0.15B -56.36%
2012-03-31 $-0.10B $0.17B -50.43%
2011-12-31 $-0.11B $0.20B -49.00%
2011-09-30 $-0.12B $0.21B -50.36%
2011-06-30 $-0.14B $0.24B -62.17%
2011-03-31 $-0.15B $0.25B -91.54%
2010-12-31 $-0.14B $0.28B -146.11%
2010-06-30 $-0.09B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.448B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.261B 26.33
Intuitive Surgical (ISRG) United States $154.295B 92.95
Edwards Lifesciences (EW) United States $53.342B 34.71
DexCom (DXCM) United States $46.386B 70.26
Alcon (ALC) Switzerland $44.049B 31.57
IDEXX Laboratories (IDXX) United States $41.591B 48.75
IQVIA Holdings (IQV) United States $38.778B 22.50
STERIS (STE) Ireland $21.402B 25.00
SONOVA HOLDING (SONVY) Switzerland $18.282B 0.00
Waters (WAT) United States $17.464B 25.67
Hologic (HOLX) United States $16.679B 18.66
Fresenius Medical Care AG KGaA (FMS) Germany $11.531B 13.46
Sysmex ADR (SSMXY) Japan $9.982B 31.30
Teleflex (TFX) United States $9.519B 14.82
Globus Medical (GMED) United States $9.073B 26.59
Masimo (MASI) United States $7.222B 41.53
Penumbra (PEN) United States $6.824B 77.55
Glaukos (GKOS) United States $5.711B 0.00
TransMedics (TMDX) United States $4.808B 456.12
Integer Holdings (ITGR) United States $3.854B 23.28
PROCEPT BioRobotics (PRCT) United States $3.188B 0.00
LivaNova (LIVN) United Kingdom $2.893B 17.18
Tandem Diabetes Care (TNDM) United States $2.766B 0.00
Nihon Kohden (NHNKY) Japan $2.661B 14.09
Inari Medical (NARI) United States $2.641B 0.00
Elekta AB (EKTAY) Sweden $2.365B 18.13
Integra LifeSciences Holdings (IART) United States $2.285B 9.97
RxSight (RXST) United States $2.111B 0.00
Veracyte (VCYT) United States $1.637B 0.00
Alphatec Holdings (ATEC) United States $1.452B 0.00
Silk Road Medical (SILK) United States $1.060B 0.00
Artivion (AORT) United States $0.967B 92.76
OPKO Health (OPK) United States $0.878B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.876B 17.05
OrthoPediatrics (KIDS) United States $0.713B 0.00
Pulse Biosciences (PLSE) United States $0.630B 0.00
IRadimed (IRMD) United States $0.536B 30.01
SiBone (SIBN) United States $0.511B 0.00
Mesa Laboratories (MLAB) United States $0.492B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.483B 0.00
Paragon 28 (FNA) United States $0.474B 0.00
Treace Medical Concepts (TMCI) United States $0.374B 0.00
Nevro (NVRO) United States $0.324B 0.00
Sight Sciences (SGHT) United States $0.318B 0.00
AxoGen (AXGN) United States $0.312B 0.00
Tactile Systems Technology (TCMD) United States $0.273B 9.34
Semler Scientific (SMLR) United States $0.263B 13.35
CVRx (CVRX) United States $0.239B 0.00
AngioDynamics (ANGO) United States $0.226B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
EDAP TMS S.A (EDAP) France $0.195B 0.00
908 Devices (MASS) United States $0.189B 0.00
NeuroPace (NPCE) United States $0.187B 0.00
Inogen (INGN) United States $0.180B 0.00
Accuray (ARAY) United States $0.173B 0.00
Alpha Tau Medical (DRTS) Israel $0.155B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Atossa Genetics (ATOS) United States $0.141B 0.00
Yubo Biotech (YBGJ) China $0.129B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.085B 17.79
InspireMD (NSPR) Israel $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Neuronetics (STIM) United States $0.055B 0.00
LENSAR (LNSR) United States $0.050B 0.00
Envoy Medical (COCH) United States $0.048B 0.00
T2 Biosystems (TTOO) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.038B 0.00
ReWalk Robotics (LFWD) Israel $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Vicarious Surgical (RBOT) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Accelerate Diagnostics (AXDX) United States $0.026B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Autonomix Medical (AMIX) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.021B 0.00
Aspira Women's Health (AWH) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00